MedPath

Prevalence of psychiatric co-morbidities in patients with early musculosceletal rheumatic diseases and non inflammatory joint diseases vs.patients without any joint disease and/or pain syndroms

Recruiting
Conditions
M13.0
F43
Polyarthritis, unspecified
Reaction to severe stress, and adjustment disorders
Registration Number
DRKS00011120
Lead Sponsor
Charité-Universitätsmedizin BerlinKlinik m.S. Rheumatologie und Klinische Immunologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
180
Inclusion Criteria

The patient
• has nflammatory and non-inflammatory joint symptoms and/or fulfills the ACR/EULAR criteria of an early RA of 2010 with a symptom duration of at least four weeks and a maximum of 12 months
• agrees with data collection of disease data and sample collection/sample use.

Age and gender-matched control population:
• Excluded inflammatory-systemic rheumatic disease
• has no other inflammatory systemic disease of the rheumatic diseases.

For all participants:
• Age = 18 years,
• There is a written consent to the survey of self-questionnaire questionnaire

Exclusion Criteria

The patient
• has a known psychiatric disorder that limits the understanding of the project plan (not consentable)
• does not agree and/or is not able to sign the declaration of consent
• is a prisoner or a person placed in an institution on the basis of an administrative or judicial order

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of psychiatric co-morbidities (by means of a psychological questionnaire package as well as a structured psychiatric interview) in early arthritis patients.
Secondary Outcome Measures
NameTimeMethod
Determination of cytocines, sensitivity of glococorticoid receptors at timepoint of diagnosis.
© Copyright 2025. All Rights Reserved by MedPath